Anti-PD-1 Therapy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

NCT07751289 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

217

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Neoadjuvant PD-1 antibody plus chemotherapy
PROCEDURE: surgery
DRUG: Adjuvant PD-1 antibody

Sponsor

Yanjie Zhang, MD